{"title":"A Comparison of Bidirectional Stratafix Continuous Suture Versus Conventional Interrupted Suture in Breast Mastectomy.","authors":"Masanori Oshi, Akimitsu Yamada, Kei Kawashima, Mahato Sasamoto, Itaru Endo","doi":"10.14740/wjon2642","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>This study aimed to compare surgical outcomes between Stratafix barbed sutures and conventional sutures in patients undergoing total mastectomy for breast cancer.</p><p><strong>Methods: </strong>This retrospective study analyzed patients who underwent total mastectomy and/or axillary lymph node dissection at our hospital.</p><p><strong>Results: </strong>A total of 29 patients were included. No significant differences were observed in clinicopathological features between the two groups. However, the percentage of suturing time within the total operative time was significantly lower in the Stratafix group compared to conventional group (10% vs. 8%). In addition, the suturing time per centimeter was also significantly shorter with Stratafix group (P < 0.001). No wound-related complications were observed in either group during at least 3 months of follow-up.</p><p><strong>Conclusions: </strong>The use of barbed sutures for wound closure in mastectomy procedures effectively reduces suturing time without increasing the incidence of wound complications. Bidirectional Stratafix barbed sutures offer an improved and efficient alternative to conventional sutures for breast surgeons.</p>","PeriodicalId":46797,"journal":{"name":"World Journal of Oncology","volume":"16 5","pages":"525-529"},"PeriodicalIF":2.2000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479069/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World Journal of Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14740/wjon2642","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: This study aimed to compare surgical outcomes between Stratafix barbed sutures and conventional sutures in patients undergoing total mastectomy for breast cancer.
Methods: This retrospective study analyzed patients who underwent total mastectomy and/or axillary lymph node dissection at our hospital.
Results: A total of 29 patients were included. No significant differences were observed in clinicopathological features between the two groups. However, the percentage of suturing time within the total operative time was significantly lower in the Stratafix group compared to conventional group (10% vs. 8%). In addition, the suturing time per centimeter was also significantly shorter with Stratafix group (P < 0.001). No wound-related complications were observed in either group during at least 3 months of follow-up.
Conclusions: The use of barbed sutures for wound closure in mastectomy procedures effectively reduces suturing time without increasing the incidence of wound complications. Bidirectional Stratafix barbed sutures offer an improved and efficient alternative to conventional sutures for breast surgeons.
期刊介绍:
World Journal of Oncology, bimonthly, publishes original contributions describing basic research and clinical investigation of cancer, on the cellular, molecular, prevention, diagnosis, therapy and prognosis aspects. The submissions can be basic research or clinical investigation oriented. This journal welcomes those submissions focused on the clinical trials of new treatment modalities for cancer, and those submissions focused on molecular or cellular research of the oncology pathogenesis. Case reports submitted for consideration of publication should explore either a novel genomic event/description or a new safety signal from an oncolytic agent. The areas of interested manuscripts are these disciplines: tumor immunology and immunotherapy; cancer molecular pharmacology and chemotherapy; drug sensitivity and resistance; cancer epidemiology; clinical trials; cancer pathology; radiobiology and radiation oncology; solid tumor oncology; hematological malignancies; surgical oncology; pediatric oncology; molecular oncology and cancer genes; gene therapy; cancer endocrinology; cancer metastasis; prevention and diagnosis of cancer; other cancer related subjects. The types of manuscripts accepted are original article, review, editorial, short communication, case report, letter to the editor, book review.